EHang Files Annual Report on Form 20-F for Fiscal Year 2022
April 27, 2023 17:40 ET
|
EHang Holdings Limited
GUANGZHOU, China, April 28, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
EHang Reports Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results
March 22, 2023 05:00 ET
|
EHang Holdings Limited
– EH216-S Type Certification (“TC”) Process Over 90% Completed– Continued High Quarterly and Annual Gross Margins of Over 65%– Post-TC Order Pipeline of EH216-S Exceeded 100 Units in China &...
Coave Therapeutics to Present at Upcoming Conferences
March 16, 2023 04:00 ET
|
Coave Therapeutics
Paris, France, March 16, 2023 - Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and eye...
EHang to Report Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results on Wednesday, March 22, 2023
March 15, 2023 08:00 ET
|
EHang Holdings Limited
GUANGZHOU, China, March 15, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
Berkshire Sterile to present on how to manage sensitive drug products, such as biologics and oligonucleotides
March 07, 2023 11:00 ET
|
Berkshire Sterile Manufacturing
Lee, MA, March 07, 2023 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM), a Massachusetts contract development and sterile manufacturing company, will describe how sensitive drug products...
Freeline Publishes Preclinical Proof-of-Concept Data for FLT190, its AAV Gene Therapy Candidate for Fabry Disease, in the Nature Journal Gene Therapy
January 19, 2023 08:01 ET
|
Freeline Therapeutics Holdings plc
Data show increased enzyme activity and reduction of harmful substrate, an established biomarker of efficacy in Fabry disease, in key tissues and organs FLT190 currently being investigated in...
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
January 17, 2023 06:00 ET
|
Forecyte Bio
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference
January 05, 2023 08:00 ET
|
Shape Therapeutics, Inc.
SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare...
EHang Announces Strategic Partnership and Investment with Qingdao West Coast New Area
December 23, 2022 08:00 ET
|
EHang Holdings Limited
GUANGZHOU, China, Dec. 23, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang Holdings Limited Announces Appointment of Nick Ning Yang as New Independent Director
December 05, 2022 07:27 ET
|
EHang Holdings Limited
GUANGZHOU, China, Dec. 05, 2022 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...